Evaluation of SARS-CoV-2-specific Serumparameters in Blood Samples of SARS-CoV-2-seronegative Volunteers as well as former Patients with Healed, Asymptomatic, Mild or Severe COVID-19-Courses (HTXCOV-01B)
Not Applicable
- Conditions
- 07.1GU09.9G
- Registration Number
- DRKS00025863
- Lead Sponsor
- Heidelberg ImmunoTherapeutics GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
1. the subject/former COVID-19 patient has given consent to participate in the study.
2. The subject/former COVID-19 patient is at least 18 years old and able to give consent.
3. evidence of at least a single positive SARS-CoV-2 smear PCR test (groups b-d) or antibody test for COVID-19.
4. sufficient information for group assignment as well as on the course of COVID-19 disease.
Exclusion Criteria
1. participants who have already been vaccinated against SARS-CoV-2 cannot participate.
2. any illness or condition which, in the opinion of the physician providing the information, does not medically allow the blood sample to be taken.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Explorative analysis - Comperative analysis of imunological parameters in serum
- Secondary Outcome Measures
Name Time Method Explorative analysis - Identification of therapeutic targets